Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Patients with Relapsed/ Refractory Large B-Cell Lymphomas

被引:0
|
作者
Balitsky, Amaris K. [1 ,2 ]
Pond, Gregory R. [2 ]
Fraser, Graeme [1 ,2 ]
Kouroukis, Tom [1 ,2 ]
Foley, Stephen Ronan [1 ,2 ]
机构
[1] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada
[2] McMaster Univ, Dept Oncol, Hamilton, ON, Canada
关键词
D O I
10.1182/blood-2022-165674
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:8036 / 8037
页数:2
相关论文
共 50 条
  • [1] Outcome after chimeric antigen receptor (CAR) T-cell therapy failure in large B-cell lymphomas
    Dodero, Anna
    Bramanti, Stefania
    Di Trani, Martina
    Pennisi, Martina
    Ljevar, Silva
    Chiappella, Annalisa
    Massimo, Magagnoli
    Guidetti, Anna
    Corrado, Francesco
    Nierychlewska, Paulina Maria
    Di Rocco, Alice
    Lorenzini, Daniele
    Daoud, Rahal
    De Philippis, Chiara
    Santoro, Armando
    Carlo-Stella, Carmelo
    Corradini, Paolo
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (01) : 151 - 159
  • [2] Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma
    Ernst, Moritz
    Oeser, Annika
    Besiroglu, Burcu
    Caro-Valenzuela, Julia
    Aziz, Mohamed Abd El
    Monsef, Ina
    Borchmann, Peter
    Estcourt, Lise J.
    Skoetz, Nicole
    Goldkuhle, Marius
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (09):
  • [3] Longitudinal Patient-Reported Outcomes in Patients Receiving Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Johnson, Patrick Connor
    Dhawale, Tejaswini
    Lavoie, Mitchell W.
    Karpinski, Kyle
    Markovitz, Netana H.
    Hennessey, Kathleen
    Frigault, Matthew
    El-Jawahri, Areej
    BLOOD, 2022, 140 : 5232 - 5233
  • [4] Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas
    Di, Mengyang
    Potnis, Kunal C.
    Long, Jessica B.
    Isufi, Iris
    Foss, Francine
    Seropian, Stuart
    Gross, Cary P.
    Huntington, Scott F.
    JNCI CANCER SPECTRUM, 2024, 8 (04)
  • [5] Chimeric antigen receptor T-cell (CAR-T) therapy in patients with aggressive B-cell lymphomas. Current outlook after a decade of treatment
    Catala, Eva
    Iacoboni, Gloria
    Barba, Pere
    MEDICINA CLINICA, 2022, 158 (07): : 327 - 332
  • [6] Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy
    Balitsky, Amaris
    Pond, G. R.
    Davies, G. A.
    Fraser, G.
    Kouroukis, T.
    Levine, M.
    Meyer, R. M.
    Foley, R.
    BMC CANCER, 2024, 24 (01)
  • [7] Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell Therapy
    Figura, Nicholas B.
    Robinson, Timothy J.
    Sim, Austin J.
    Wang, Xuefeng
    Cao, Biwei
    Chavez, Julio C.
    Shah, Bijal D.
    Khimani, Farhad
    Lazaryan, Aleksandr
    Davila, Marco
    Bachmeier, Christina
    Nishihori, Taiga
    Liu, Hien D.
    Kim, Sungjune
    Locke, Frederick L.
    Jain, Michael D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (05): : 1145 - 1154
  • [8] Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma
    Lutfi, Forat
    Holtzman, Noa
    Siglin, Jonathan
    Bukhari, Ali
    Mustafa Ali, Moaath
    Kim, Dong
    Sanchez-Petitto, Gabriela
    Gottlieb, David
    Ruehle, Kathleen
    Hutnick, Elizabeth
    Gahres, Natalie
    Hankey, Kim
    Lee, Seung
    Kocoglu, Mehmet
    Yared, Jean
    Hardy, Nancy
    Rapoport, Aaron
    Dahiya, Saurabh
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : 212 - 216
  • [9] Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy
    Johnson, P. Connor
    Dhawale, Tejaswini
    Newcomb, Richard A.
    Amonoo, Hermioni L.
    Lavoie, Mitchell W.
    Vaughn, Dagny
    Karpinski, Kyle
    El-Jawahri, Areej
    BLOOD ADVANCES, 2023, 7 (14) : 3541 - 3550
  • [10] Chimeric Antigen Receptor T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Multicenter Study
    Tun, Aung M.
    Patel, Romil
    St-Pierre, Frederique
    Ouchveridze, Evguenia
    Niu, Alex
    Obasi, Jennifer
    Rosenthal, Allison C.
    Pophali, Priyanka A.
    Fenske, Timothy S.
    Karmali, Reem
    Ahmed, Sairah
    Johnston, Patrick B.
    BLOOD, 2023, 142